SEC Form 4 · accession 0000898432-18-000901
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher K. Scott
Officer — CFO
Period of report
Aug 6, 2018
Accepted (ET)
Aug 8, 2018 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 6, 2018 | A | 26,297 | $1.48 | A | 32,398 | D | |
| Common StockF1 | Aug 6, 2018 | S | 26,297 | $26.1591 | D | 6,101 | D | |
| Common Stock | Aug 7, 2018 | A | 66,046 | $1.48 | A | 72,147 | D | |
| Common StockF2 | Aug 7, 2018 | S | 66,046 | $26.0285 | D | 6,101 | D | |
| Common Stock | Aug 8, 2018 | A | 3,907 | $1.48 | A | 10,008 | D | |
| Common StockF3 | Aug 8, 2018 | S | 3,907 | $25.7649 | D | 6,101 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $1.48 | Aug 6, 2018 | M | 26,297 | D | — | Dec 29, 2023 | Common Stock | 26,297 | 69,953 | D |
| Stock Option (Right to Buy)F4 | $1.48 | Aug 7, 2018 | M | 66,046 | D | — | Dec 29, 2023 | Common Stock | 66,046 | 3,907 | D |
| Stock Option (Right to Buy)F4 | $1.48 | Aug 8, 2018 | M | 3,907 | D | — | Dec 29, 2023 | Common Stock | 3,907 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $26.00 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $26.00 to $26.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $25.50 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.